Business Analyst, Market Intelligence
Listed on 2026-08-08
-
Business
Business Analyst, Data Analyst
About Orchestra Life Sciences
Orchestra Life Sciences (OLS) is a specialized technical advisory consultancy serving the radiopharmaceutical, cell and gene therapy, and broader advanced therapies sectors. We partner with developers, manufacturers, investors, and strategic stakeholders to navigate the complex intersection of GMP manufacturing, regulatory strategy, supply chain, and commercial scale-up. Our team brings deep sector expertise and a hands-on approach to accelerating client programs from development through commercialization.
Location: St. Louis, MO
Company: Orchestra Life Sciences
Reports to: Managing Director
Employment Type: Full-Time
About Orchestra Life Sciences
Orchestra Life Sciences (OLS) is a specialized technical advisory consultancy serving the radiopharmaceutical, cell and gene therapy, and broader advanced therapies sectors. We partner with developers, manufacturers, investors, and strategic stakeholders to navigate the complex intersection of GMP manufacturing, regulatory strategy, supply chain, and commercial scale-up. Our team brings deep sector expertise and a hands-on approach to accelerating client programs from development through commercialization.
Role Summary
OLS is seeking a high-impact Business Analyst, Market Intelligence to support our growing strategic advisory practice. This individual will serve as the analytical engine behind OLS’s most consequential client engagements and internal intelligence products — producing rigorous, insight-rich research across the advanced therapies landscape. The ideal candidate combines deep command of data and forecasting tools with the intellectual curiosity to connect macro trends, clinical pipeline signals, competitive dynamics, and policy shifts into clear, executive-ready intelligence.
This role operates at the intersection of science, strategy, and business — and requires someone who is equally comfortable building a bottom-up demand model and presenting key takeaways to a CEO.
Key Responsibilities
Market & Competitive Intelligence
- Track and synthesize clinical pipeline developments across radiopharmaceuticals, cell and gene therapy, and adjacent advanced modalities, including IND filings, trial initiations, phase progressions, and approval timelines
- Build and maintain competitive landscapes covering sponsors, CDMOs, isotope producers, platform developers, and service providers
- Monitor and analyze M&A activity, licensing deals, strategic partnerships, and investment flows across the sector
- Identify white space opportunities, emerging therapeutic targets, and platform technology shifts relevant to OLS clients
Data Analysis & Forecasting
- Develop quantitative models for market sizing, demand forecasting, capacity analysis, and revenue projection across therapeutic isotopes, drug programs, and enabling technologies
- Apply forecasting methodologies (CAGR modeling, scenario analysis, regression, Monte Carlo) to support client recommendations and strategic planning deliverables
- Synthesize data from proprietary, public, and commercial sources (clinical registries, FDA/EMA databases, earnings calls, investor presentations, scientific literature) into structured, reproducible analytical frameworks
- Perform value chain and margin analysis, including per-dose economics, pricing benchmarking, and supply/demand gap modeling
- Track FDA, EMA, and international regulatory agency guidance, final rules, draft guidances, and enforcement trends relevant to advanced therapies manufacturing and drug development
- Monitor REMS programs, CMC requirements, sterility frameworks, and quality system developments impacting client programs
- Summarize policy and reimbursement landscape trends, including CMS coverage decisions, ICER analyses, and global pricing dynamics
- Synthesize venture capital, private equity, and strategic investment trends across the advanced therapies and nuclear medicine ecosystems
- Monitor government funding programs, DOE/DOD initiatives, NCI grants, and international public sector investment in radiopharmaceuticals and advanced modalities
- Track macroeconomic and geopolitical factors impacting…
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).